49.92

1.46% 0.72

Prestige Consumer Healthcare Inc (PBH)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Prestige Consumer Healthcare Inc stock is traded at $49.92, with a volume of 580.63K. It is up +1.46% in the last 24 hours and up +6.53% over the past month. Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Previous Close:

$49.20

Open:

$49.48

24h Volume:

580.63K

Relative Volume:

1.09

Market Cap:

$2.36B

Revenue:

$1.10B

Net Income/Loss:

$186.50M

P/E Ratio:

13.20

EPS:

3.7817

Net Cash Flow:

$267.19M

1W Performance:

+3.50%

1M Performance:

+6.53%

6M Performance:

-12.50%

1Y Performance:

-19.24%

1-Day Range:

$49.28

$50.27

1-Week Range:

$47.80

$50.84

52-Week Range:

$42.62

$71.07

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Name

Prestige Consumer Healthcare Inc

Sector

Healthcare (1052)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(914) 524-6800

Address

660 WHITE PLAINS RD., TARRYTOWN, NY

Employee

890

Twitter

Next Earnings Date

2026-11-05

Latest SEC Filings

PBH's Discussions on Twitter

Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBH Prestige Consumer Healthcare Inc	49.92	2.36B	1.10B	186.50M	267.19M	3.7817
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-14-26	Downgrade	Oppenheimer	Outperform → Perform
Sep-24-25	Upgrade	Sidoti	Neutral → Buy
Dec-09-24	Downgrade	Sidoti	Buy → Neutral
Jun-21-24	Upgrade	DA Davidson	Neutral → Buy
Nov-17-22	Initiated	Canaccord Genuity	Buy
May-10-22	Upgrade	Jefferies	Hold → Buy
May-09-22	Upgrade	Oppenheimer	Perform → Outperform
Aug-07-20	Downgrade	DA Davidson	Buy → Neutral
Jun-29-20	Upgrade	Sidoti	Neutral → Buy
Apr-14-20	Downgrade	Jefferies	Buy → Hold
Apr-07-20	Resumed	Sidoti	Neutral
Mar-26-20	Upgrade	Jefferies	Hold → Buy
Mar-24-20	Initiated	Oppenheimer	Perform
Mar-19-20	Upgrade	DA Davidson	Neutral → Buy
Jan-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-04-17	Upgrade	William Blair	Mkt Perform → Outperform
Jun-02-17	Upgrade	Jefferies	Underperform → Hold
May-22-17	Upgrade	Raymond James	Mkt Perform → Outperform
Dec-27-16	Reiterated	B. Riley & Co.	Buy
Nov-17-16	Initiated	Gabelli & Co	Buy
Aug-12-16	Upgrade	Sidoti	Neutral → Buy
Mar-08-16	Initiated	KeyBanc Capital Mkts	Overweight
Feb-05-16	Initiated	Piper Jaffray	Overweight
Nov-30-15	Downgrade	Jefferies	Hold → Underperform
Apr-28-14	Reiterated	B. Riley & Co.	Buy
Apr-28-14	Reiterated	Oppenheimer	Outperform
Jul-09-13	Initiated	B. Riley & Co.	Buy

View All

Prestige Consumer Healthcare Inc Stock (PBH) Latest News

Oct 15, 2026

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research

Oct 15, 2026

Oct 14, 2026

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results - Yahoo Finance

Oct 14, 2026

How InvestingPro spotted Prestige Healthcare’s 43% stock decline By Investing.com - Investing.com

Oct 14, 2026

Oct 09, 2026

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $PBH - MarketBeat

Oct 09, 2026

Oct 08, 2026

What Does the Guidance Raise Mean for Prestige Consumer (NYSE:PBH)? - Kalkine Media

Oct 08, 2026

Oct 07, 2026

Prestige Consumer Healthcare stock falls 11% on Q4 revenue decline - scanx.trade

Oct 07, 2026

Prestige Consumer Q1FY27 Results: Revenue rises 6.5% to $266 million - scanx.trade

Oct 07, 2026

Transcript: Prestige Consumer Q1 2027 Earnings Conference Call - Benzinga

Oct 07, 2026

Prestige Consumer Latest Results: Sales guidance rises to $1.29B-$1.315B - scanx.trade

Oct 07, 2026

PBH vs. NEOG: Which Stock Is the Better Value Option? - Zacks Investment Research

Sep 30, 2026

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times

Sep 30, 2026

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times

Sep 30, 2026

Sep 29, 2026

Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings? - Yahoo Finance

Sep 29, 2026

Sep 28, 2026

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets - Yahoo Finance

Sep 28, 2026

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - Yahoo Finance

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView

Sep 27, 2026

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView

Sep 27, 2026

Sep 24, 2026

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com India

Sep 24, 2026

Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com

Sep 24, 2026

Sep 23, 2026

A Look at Prestige Consumer Healthcare Inc (PBH) After 3.8% Decl - GuruFocus

Sep 23, 2026